Mendelsohn Michael 4
4 · Cyclerion Therapeutics, Inc. · Filed Jun 16, 2022
Insider Transaction Report
Form 4
Mendelsohn Michael
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-14+20,000→ 20,000 totalExercise: $0.53Exp: 2032-06-14→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date.